Rigrodsky & Long, P.A. Investigates NovaMed, Inc. Buyout

  • Do you own NovaMec, Inc. common stock?
  • Did you purchase your shares prior to January 21, 2011?
  • Do you feel the buyout is unfair?
  • Do you want to discuss your rights?

If the answer to these questions is "yes," please contact the deal lawyers at Rigrodsky & Long, P.A. ("R & L") today to schedule a FREE consultation. Just call us, or fill out our contact form so that we can call at your convenience. Your consultation will not create any obligation to use our services at any time.

Contact R & L today to be sure your best interests are being protected.

R & L is national law firm with decades of combined legal experience. R & L is investigating potential claims against the board of directors of NovaMed, Inc. concerning possible breaches of fiduciary duty and other violations of law related to the Company’s entry into an agreement to be acquired and taken private by Surgery Center Holdings, Inc., an affiliate of H.I.G. Capital, LLC, in a transaction valued at approximately $214 million.

Click here to read the full press release.

Rigrodsky & Long, P.A. Investigates NovaMed, Inc. Buyout

Rigrodsky & Long, P.A. announces that it is investigating potential claims against the board of directors of NovaMed, Inc. (“NovaMed” or the “Company”) (Nasdaq: NOVA) concerning possible breaches of fiduciary duty and other violations of law related to the Company’s entry into an agreement to be acquired and taken private by Surgery Center Holdings, Inc. (“Surgery Partners”), an affiliate of H.I.G. Capital, LLC, in a transaction valued at approximately $214 million.

Under the proposed agreement, Surgery Partners will acquire all of the outstanding common shares of NovaMed for $13.25 per share in cash. Furthermore, certain NovaMed directors and officers that in the aggregate own approximately 10.5% of NovaMed’s outstanding shares have entered into agreements with Surgery Partners to vote in favor of the merger.

The investigation concerns whether NovaMed’s board of directors failed to adequately shop the Company and obtain the best price possible for NovaMed’s shareholders before entering into the agreement with Surgery Partners. Indeed, according to Yahoo! Finance, at least one analyst has set an $18.00 per share price target for NovaMed stock.

If you own the common stock of NovaMed and purchased your shares before January 21, 2011, if you have information or would like to learn more about these claims, or if you wish to discuss these matters or have any questions concerning this announcement or your rights or interests with respect to these matters, please contact Seth D. Rigrodsky, Esquire or Noah R. Wortman, Case Development Director, of Rigrodsky & Long, P.A., 919 N. Market Street, Suite 980, Wilmington, Delaware, by telephone at (888) 969-4242, or by e-mail to info@rigrodskylong.com.

Rigrodsky & Long, P.A., with offices in Wilmington, Delaware and Garden City, New York, regularly litigates securities class, derivative and direct actions, shareholder rights litigation and corporate governance litigation, including claims for breach of fiduciary duty and proxy violations in the Delaware Court of Chancery and in state and federal courts throughout the United States.

Attorney advertising. Prior results do not guarantee a similar outcome.

R & L, with offices in Delaware and New York, litigates securities class, derivative and direct actions, shareholder rights litigation and corporate governance litigation, including claims for breach of fiduciary duty and proxy violations in the Delaware Court of Chancery and in state and federal courts throughout the United States.

Attorney advertising.  Prior results do not guarantee a similar outcome.

Learn more about R&L:  Visit Our Website |  Our Firm  |  Our Practice Areas  |  FAQ's

Fill out the form below or call us toll-free at 888-969-4242, for a FREE no-obligation consultation.